|ACPM Headlines 10/19/13|
In this Issue
Policy and Practice
Research and Reports
1. ACPM BOARD ADOPTS GOVERNANCE CHANGES
The Board of Regents has adopted changes to ACPM’s governance structures consistent with proposals shared with the membership in early September. The changes, which were adopted at the Board’s October 1 meeting and will be phased in over time beginning in 2014, will reduce the size of the Board from 16 to 12, convert categorical and regional regent positions to at-large positions, elect at-large regents as part of a slate of candidates, and create a board/leadership development committee to provide leadership and governance education to aspiring members and identify and groom members for specific leadership positions.
The intent of the changes is to streamline Board operations and decision making, assure competency-driven governance that can both navigate the rapidly changing health care environment and position the organization for long-term success, and develop a pipeline of leaders within the organization ready to lead. The Board’s actions were based on proposals outlined in a September 6 letter from ACPM Past-President Miriam Alexander to the membership as well as in a September 11 webinar, although the Board amended the implementation schedule to make the changes effective beginning with elections in 2015, not 2014. The changes will be presented again to the membership at the College’s annual business session/Town Hall meeting on February 21 at Preventive Medicine 2014.
Also at its meeting, the Board of Regents:
For more information on these or any other actions of the Board of Regents, contact ACPM executive director Mike Barry.
The United States Preventive Services Task Force (USPSTF) has released final recommendation statements on Screening for Primary Hypertension in Children and Adolescents and Medications for Risk Reduction of Primary Breast Cancer in Women. USPSTF issued an I statement for primary hypertension screening in children and adolescents, concluding there is insufficient evidence to recommend this practice. USPSTF provided a B recommendation for primary breast cancer risk reduction, encouraging clinicians to discuss with women at increased risk of breast cancer about taking medications that may reduce their risk.
In addition, USPSTF issued a draft recommendation statement and draft evidence report on Primary Care Behavioral Interventions to Reduce Illicit Drug and Nonmedical Pharmaceutical Use in Children and Adolescents. Comments will be accepted until October 28th, 2013.
ACPM is sponsoring multiple clinical risk management and pharmacovigilance job opportunities for early-to-mid-career preventive medicine physicians at Otsuka Pharmaceutical Development & Commercialization, Inc. Successful applicants will be offered a full-time position monitoring the efficacy of Otsuka’s global drug and device products. The initial two-year training period includes rotating through different departments within Otsuka’s drug safety division in Princeton, New Jersey. Annual salary starts at $150,000, including benefits.
If you are interested, please send a copy of your CV and a statement of interest to Andrea Lowe, ACPM Policy and Practice Manager, at firstname.lastname@example.org.
4. ACPM ISSUES CALL FOR AWARDS AND BOARD NOMINATIONS
Annually, ACPM recognizes individuals for significant contributions, dedication and service to the College and preventive medicine. ACPM currently is accepting nominations for the following awards: Ron Davis Distinguished Service, Special Recognition, William Kane Rising Star, and Donald Gemson Resident Award. Nominations for Awards are due Friday, November 22, 2013. Award recipients will be recognized during the ACPM Annual Meeting, Preventive Medicine 2014. Please consider nominating a deserving colleague for one of these awards!
Board of Regents
ACPM also is pleased to announce the Call for Nominations to fill upcoming vacancies on the ACPM Board of Regents. Elections will be held in early-2014 for Secretary, Treasurer, Occupational Medicine Regent, and regents for the Northeast and Midwest regions.
To submit a nomination, or if you would like to be considered for any of the vacancies listed above, please submit a nomination letter, with the proposed candidate’s curriculum vitae (CV) through ACPM’s website. Both a nomination letter and CV are required for consideration. All candidates must be active ACPM Fellows. If nominated for a Regional Regent position, candidates must reside in the region they wish to represent.
Election winners will be announced during the ACPM annual meeting, Preventive Medicine 2014. Please take a moment and consider whether you or someone you know would be a good choice for a leadership position with ACPM. Also, before submitting a nomination, please check with the member to ensure they are an active ACPM Fellow, meet regional residency requirements (if applicable), and would be willing to accept the nomination. Nominations for Board of Regents positions are due Friday, November 22, 2013.
In his inaugural speech last February, ACPM President Halley Faust MD, MPH, FACPM, highlighted three priorities for his presidency: sustainability, innovation, and imagination. His innovation priority, which will serve as the theme for Preventive Medicine 2014, also was the theme of ACPM’s recent Corporate Roundtable meeting, which took place at ACPM headquarters on Monday, September 30. Ron Joines, MD, MPH, Vice President, Medical Director Environmental Health & Safety Technical COE, GlaxoSmithKline (GSK), delivered the keynote "The Role of Preventive Medicine in Driving Private Sector Performance of a Corporation.”
In a second session "Emerging Technological Innovations in Healthcare,” Corporate Roundtable members explored how new technological innovations are transforming a variety of settings including health plans, clinical practices, and the government. The session was led by Pat Keran, Sr. Director, Innovation Research and Development, UnitedHealth Group, and Jessie James, MD, MBA, Managing Director, Clinical Informatics, EvolentHealth, and former Senior Medical Officer, Meaningful Use, Office of the National Coordinator for Health IT, HHS.
ACPM’s Corporate Roundtable is an ongoing forum for mission-aligned private sector organizations to discuss and advance issues of shared interest with the College.Corporate Roundtable members meet twice annually, once in September at ACPM headquarters in Washington, DCand once at the Preventive Medicine conference held each year in February. ACPM has welcomed five new members to the roundtable in 2013—Cerner, Health Diagnostics Laboratory, MDVIP, Sanofi Aventis, and UnitedHealth Group. Learn more about ACPM’s Corporate Roundtable.
ACPM’s Membership Manager, Camille Sanders, has accepted a position with another organization—a DC-based political action committee—and is leaving the College, effective October 18. Camille joined ACPM in May 2012 and, although with the College for a relatively short period, left her mark on the Membership Department.
Among her accomplishments, Camille, working with the Membership Committee, developed and began execution of the membership department’s first formal marketing plan to support acquisition and retention efforts; created a membership policy and procedures manual as well as a user-friendly training manual for various membership database functions; increased ACPM’s member retention rate; vastly enhanced communications with and engagement of ACPM’s membership sections for medical students, residents, and young physicians; and launched several new program initiatives, such as medical student chapter development and redesign of ACPM’s education web portal.
Camille’s enthusiasm for serving ACPM’s members, association professional experience, and positive persona will be missed by members and staff alike. Please join us in wishing her well in her new endeavors.
7. ACPM JOINS SIGN ON LETTER URGING FDA REGULATION OF E-CIGARETTES
ACPM joined its public health and medicine partner organizations on a sign-on letter to President Obama urging Food and Drug Administration (FDA) oversight over all tobacco products including e-cigarettes and cigars. The letter specifically requests that the President work to release a long-delayed proposed rule to assert FDA jurisdiction over all types of tobacco products. The Tobacco Control Act originally limited FDA’s authority to cigarettes and smokeless tobacco, yet allows the agency to expand its authority through rulemaking to any and all types of tobacco products.
The letter noted, "The use of e-cigarettes is increasing, including among youth. The e-cigarette industry is using a number of marketing techniques originally employed by the cigarette companies to addict youth, including the use of candy- and fruit-flavors. E-cigarettes come in cotton candy, gummy bear, bubble gum flavors, Atomic Fireball, orange soda, as well as grape, apple and strawberry. Earlier this month, the Centers for Disease Control and Prevention (CDC) released alarming new data about e-cigarette use among youth. In just one year (2011 to 2012), the number of students in grades 6-12 reporting having ever used an e-cigarette doubled from 3.3 percent to 6.8 percent.”
Meanwhile, Democrats in the U.S. House of Representatives and Senate have sent letters to nine companies asking them to explain e-cigarette marketing tactics that target children.
A set of restrictions on selling flavored cigarettes and other non-cigarette products was upheld this week by the First Circuit Court of Appeals in Providence, R.I. The court also upheld a ban on marketing techniques like coupons and buy-two-get-one-free deals, rejecting tobacco companies’ arguments that the measures violated their first amendment rights.
Click here to view the appeals decision.
With the implementation of the Physician Payments Sunshine Act, ACPM, through the Partners for Healthy Dialogues coalition, is working to provide clear, helpful information to its members. Partners for Healthy Dialogues is a collaboration between health care provider organizations and biopharmaceutical and medical technology organizations to highlight the value of interactions between physicians and biopharmaceutical/medical technology companies, from better patient care to advancing medical innovation.
As of August 1, biopharmaceutical and medical technology companies began collecting data on payments and transfers of value paid or given to physicians and teaching hospitals. Next year, this data will be reported to the Centers for Medicare & Medicaid Services (CMS). CMS will release a public database of this information in September 2014.
So, what can you do now? It’s important to review your National Provider Identifier (NPI) profile and ensure that all of your information is up to date. Partners for Healthy Dialogues developed a video about updating your NPI – click here to watch the video and to learn more about the Sunshine Act.
10. IOM RELEASES REPORT ON POPULATION HEALTH IMPLICATIONS OF THE AFFORDABLE CARE ACT
The Institute of Medicine (IOM) has released Population Health Implications of the Affordable Care Act, a summary of a recent IOM Roundtable on Population Health Improvement workshop. The summary includes presentations from public health and health care leaders that notes the current state of population health, proposals for the future, and how best to sustain population health concepts within new or existing initiatives and programs. The summary highlights the importance of collaboration among multiple stakeholders, community engagement, and the need for a strong infrastructure and leadership to successfully improve population health.
A recent report by Trust for America’s Health (TFAH), "Prescription Drug Abuse: Strategies to Stop the Epidemic,” unveils successful approaches to curb prescription drug abuse. Prescription drug abuse has rapidly become a national public health priority because of the rising death toll of prescription drug related deaths. According to the report, prescription drug related deaths now exceed motor vehicle-related deaths in 29 states and the District of Columbia. Additionally, misuse and abuse of prescription drugs costs the U.S. an estimated $53.4 billion a year in lost productivity, medical costs and criminal justice costs.
The report identifies four overarching strategies to curtail the prescription drug abuse epidemic: (1) improving prescription drug monitoring programs; (2) ensuring access to substance abuse treatment; (3) ensuring responsible prescribing practices; and, (4) expanding public education and building community partnerships.
To find state-by-state prescription drug overdose death rates and learn how your state scores on 10 key steps to curb abuse, visit http://ow.ly/pGYDT.
The Institute of Medicine (IOM) has released Ranking Vaccines: A Prioritization Software Tool (Phase II: Prototype of a Decision-Support System), as a follow-up to a 2012 report on vaccine prioritization efforts.
The tool is intended to help population health decision makers prioritize vaccines based on demographics, disease burden, vaccine efficacy and uptake characteristics. The tool develops a SMART score for each vaccine candidate based on data users’ input into the system.
The tool is currently available for download from the National Academies Press.
13. CDC ANNOUNCES APPLIED EPIDEMIOLOGY FELLOWSHIP FOR MEDICAL STUDENTS
The U.S. Centers for Disease Control and Prevention (CDC) is accepting applications for "The CDC Experience Applied Fellowship,” which targets second or third year medical students with an interest in applied epidemiology and public health. CDC will select eight fellows who will spend 10-12 months at the CDC in Atlanta conducting epidemiologic analyses in their area of interest, such as chronic disease, global health, or injury prevention. Fellows will have the opportunity to improve their skills in research and analytics, written and oral presentations, and the practice of preventive medicine and public health.
Applications will be accepted through December 6th, 2013.
The National Institutes of Health (NIH) is offering funding opportunities for Research on the Health Determinants and Consequences of Violence and its Prevention, Particularly Firearm Violence. These R01 (Research Project Grant), R03 (Small Grant Program), and R21 (Exploratory/Developmental Grant) grants will provide academic, non-profit, for-profit, governments, and other institutions with the opportunity to advance research on the etiology and public health consequences of violence. Applications will be open until February 5th (R01 grant) or February 16th (R03 and R21) for new applicants.
The Council on Linkages Between Academia and Public Health Practice (Council on Linkages) is seeking feedback from the public health community on its proposed revisions to the Core Competencies for Public Health Professionals to ensure that these competencies keep pace with changes in the field of public health and continue to reflect the skills needed by public health professionals. Multiple opportunities to provide feedback exist, including through an online feedback form. Feedback will be accepted through December, 2013.
ACPM member Beverly Taylor, MD, MPH is ACPM’s representative to the Council on Linkages and is working with ACPM to promote opportunities for preventive medicine physicians to influence the proposed changes.